干细胞捐献者不应进行克隆性造血筛查。
Stem cell donors should not be screened for clonal hematopoiesis.
机构信息
Division of Hematological Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
出版信息
Blood Adv. 2020 Feb 25;4(4):789-792. doi: 10.1182/bloodadvances.2019000395.
Abstract
This article has a companion Point by DeZern and Gondek.
摘要
本文有 DeZern 和 Gondek 的观点与之对应。
相似文献
1
Stem cell donors should not be screened for clonal hematopoiesis.干细胞捐献者不应进行克隆性造血筛查。
Blood Adv. 2020 Feb 25;4(4):789-792. doi: 10.1182/bloodadvances.2019000395.
2
Clonal hematopoiesis of indeterminate potential in older patients having received an allogeneic stem cell transplantation from young donors.接受年轻供者异基因干细胞移植的老年患者中的不确定潜能克隆性造血。
Bone Marrow Transplant. 2020 Mar;55(3):665-668. doi: 10.1038/s41409-019-0575-4. Epub 2019 May 30.
3
Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management.相关异基因移植供体中的克隆性造血：对筛查和管理的启示
Biol Blood Marrow Transplant. 2020 Jun;26(6):e142-e144. doi: 10.1016/j.bbmt.2020.02.022. Epub 2020 Mar 5.
4
[Clonal hematopoiesis: a risk factor for leukemia and cardiovascular disease?].[克隆性造血：白血病和心血管疾病的危险因素？]
Ned Tijdschr Geneeskd. 2020 Nov 5;164:D5205.
5
The Clinical Management of Clonal Hematopoiesis: Creation of a Clonal Hematopoiesis Clinic.克隆性造血的临床管理：克隆性造血临床的建立。
Hematol Oncol Clin North Am. 2020 Apr;34(2):357-367. doi: 10.1016/j.hoc.2019.11.006. Epub 2020 Jan 18.
6
A Single-Cell Analysis of DNMT3A-Mediated Clonal Hematopoiesis in Heart Failure.心力衰竭中DNMT3A介导的克隆性造血的单细胞分析
Circ Res. 2021 Jan 22;128(2):229-231. doi: 10.1161/CIRCRESAHA.120.318575. Epub 2021 Jan 21.
7
Clonal hematopoiesis of indeterminate potential in the companion dog.伴侣犬中具有不确定潜能的克隆性造血
Leukemia. 2022 May;36(5):1401-1403. doi: 10.1038/s41375-022-01520-5. Epub 2022 Feb 10.
8
Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells.克隆性造血、心血管疾病与造血干细胞
Int J Mol Sci. 2020 Oct 24;21(21):7902. doi: 10.3390/ijms21217902.
9
Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation.供者和相关异基因造血干细胞移植长期存活者中的克隆性造血。
Blood. 2020 Apr 30;135(18):1548-1559. doi: 10.1182/blood.2019003079.
10
Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.异基因造血细胞移植后嵌合供体源性造血与需要免疫抑制治疗的慢性移植物抗宿主病相关，但对总生存或复发无不良影响。
Transplant Cell Ther. 2021 Aug;27(8):662.e1-662.e9. doi: 10.1016/j.jtct.2021.04.014. Epub 2021 Apr 24.
引用本文的文献
1
Clonal hematopoiesis in myeloid malignancies and solid tumors.髓系恶性肿瘤和实体瘤中的克隆性造血
Nat Cancer. 2025 Jul 18. doi: 10.1038/s43018-025-01014-0.
2
Donor Cell-Derived Chronic Lymphocytic Leukemia Presenting After Allogenic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.急性髓系白血病异基因造血干细胞移植后出现供体细胞来源的慢性淋巴细胞白血病
J Hematol. 2025 Apr;14(2):79-85. doi: 10.14740/jh2022. Epub 2025 Feb 21.
3
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part III. Long-Term Impact of Chronic Graft-versus-Host Disease on Endocrinologic, Cardiovascular, and Metabolic Outcomes in Survivors of Pediatric Hematopoietic Cell Transplantation.儿科移植与细胞治疗联盟造血细胞移植后小儿慢性移植物抗宿主病幸存者的RESILIENT会议：第三部分。慢性移植物抗宿主病对小儿造血细胞移植幸存者内分泌、心血管和代谢结局的长期影响。
Transplant Cell Ther. 2025 May;31(5):297.e1-297.e15. doi: 10.1016/j.jtct.2025.01.891. Epub 2025 Feb 12.
4
Stem cell graft dose and composition could impact on the expansion of donor-derived clones after allogeneic hematopoietic stem cell transplantation - a virtual clinical trial.干细胞移植剂量和组成可能会影响异基因造血干细胞移植后供体来源克隆的扩增——一项虚拟临床试验。
Front Immunol. 2024 Dec 16;15:1321336. doi: 10.3389/fimmu.2024.1321336. eCollection 2024.
5
Effects of donor-engrafted clonal hematopoiesis in allogeneic and autologous stem cell transplantation: a systematic review and meta-analysis.供者嵌合性造血在异基因和自体造血干细胞移植中的作用：系统评价和荟萃分析。
Bone Marrow Transplant. 2024 Nov;59(11):1585-1593. doi: 10.1038/s41409-024-02403-2. Epub 2024 Aug 25.
6
Facilitating the ethical sourcing of donor hematopoietic stem cells for cell and gene therapy research and development.促进用于细胞和基因治疗研发的供者造血干细胞的合乎伦理的来源。
Regen Med. 2024 Jun 2;19(6):317-326. doi: 10.1080/17460751.2024.2357930. Epub 2024 Jun 18.
7
Clonal hematopoiesis in the setting of hematopoietic cell transplantation.造血干细胞移植背景下的克隆性造血。
Semin Hematol. 2024 Feb;61(1):9-15. doi: 10.1053/j.seminhematol.2024.01.011. Epub 2024 Feb 1.
8
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.多中心、前瞻性临床研究 Omidubicel 异基因造血干细胞移植的长期随访：五项研究的汇总分析。
Transplant Cell Ther. 2023 May;29(5):338.e1-338.e6. doi: 10.1016/j.jtct.2023.01.031. Epub 2023 Feb 10.
9
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up.供者克隆性造血不会影响异基因造血干细胞移植后的长期预后：一项 13 年随访研究结果。
Haematologica. 2023 Jul 1;108(7):1817-1826. doi: 10.3324/haematol.2022.281806.
10
Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies.克隆性造血：在血液系统和非血液系统恶性肿瘤中的作用
Mediterr J Hematol Infect Dis. 2022 Sep 1;14(1):e2022069. doi: 10.4084/MJHID.2022.069. eCollection 2022.
本文引用的文献
1
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.供者克隆性造血在异基因造血干细胞移植中的作用。
J Clin Oncol. 2019 Feb 10;37(5):375-385. doi: 10.1200/JCO.2018.79.2184. Epub 2018 Nov 7.
2
Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trial.李-佛美尼综合征的诊断：从克隆性造血中区分 TP53 种系突变：观察性 AGO-TR1 试验的结果。
Hum Mutat. 2018 Dec;39(12):2040-2046. doi: 10.1002/humu.23653. Epub 2018 Oct 3.
3
Concise Review: Age-Related Clonal Hematopoiesis: Stem Cells Tempting the Devil.简明综述：与年龄相关的克隆性造血：干细胞诱惑魔鬼。
Stem Cells. 2018 Sep;36(9):1287-1294. doi: 10.1002/stem.2845. Epub 2018 Jun 8.
4
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.TET2 缺失可增强 CD19 靶向 T 细胞的治疗效果。
Nature. 2018 Jun;558(7709):307-312. doi: 10.1038/s41586-018-0178-z. Epub 2018 May 30.
5
Lineage restriction analyses in CHIP indicate myeloid bias for and multipotent stem cell origin for .CHIP 中的谱系限制分析表明 偏向于髓系，而 起源于多能干细胞。
Blood. 2018 Jul 19;132(3):277-280. doi: 10.1182/blood-2018-01-829937. Epub 2018 May 15.
6
Misdiagnosis of Li-Fraumeni Syndrome in a Patient With Clonal Hematopoiesis and a Somatic Mutation.患者存在克隆性造血和体细胞突变，导致 Li-Fraumeni 综合征误诊。
J Natl Compr Canc Netw. 2018 May;16(5):461-466. doi: 10.6004/jnccn.2017.7058.
7
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis.克隆性造血的造血谱系分布和进化动态。
Leukemia. 2018 Sep;32(9):1908-1919. doi: 10.1038/s41375-018-0047-7. Epub 2018 Mar 1.
8
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.非血液系统恶性肿瘤患者治疗相关克隆性造血很常见，并与不良临床结局相关。
Cell Stem Cell. 2017 Sep 7;21(3):374-382.e4. doi: 10.1016/j.stem.2017.07.010. Epub 2017 Aug 10.
9
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.克隆性造血与动脉粥样硬化性心血管疾病风险
N Engl J Med. 2017 Jul 13;377(2):111-121. doi: 10.1056/NEJMoa1701719. Epub 2017 Jun 21.
10
Current Use and Trends in Hematopoietic Cell Transplantation in the United States.美国造血细胞移植的当前应用与趋势
Biol Blood Marrow Transplant. 2017 Sep;23(9):1417-1421. doi: 10.1016/j.bbmt.2017.05.035. Epub 2017 Jun 9.
Zotero 插件